APOL logo

Apollon Formularies PLC Stock Price

OFEX:APOL Community·UK£57.8k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

APOL Share Price Performance

UK£0
0.00 (0.00%)
UK£0
0.00 (0.00%)
Price UK£0

APOL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Weak fundamentals or lack of information.

4 Risks
0 Rewards

Apollon Formularies PLC Key Details

UK£362.7k

Revenue

UK£0

Cost of Revenue

UK£362.7k

Gross Profit

UK£1.4m

Other Expenses

-UK£1.0m

Earnings

Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About APOL

Founded
2014
Employees
n/a
CEO
Stephen Barnhill
WebsiteView website
www.apollon.org.uk

Apollon Formularies PLC operates as a medical cannabis pharmaceutical company. It offers hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products, such as cannabis oil vape, oral tincture, and perscribed capsules under the Apollon NAUSEA, Apollon PAIN, Apollon SLEEP, Apollon ANTI-INFLAMMATORY, Apollon SEIZURES, Apollon APPETITE, and Apollon CANCER names. Apollon Formularies PLC was founded in 2014 and is based in Douglas, the United Kingdom.

Recent APOL News & Updates

Recent updates

No updates

Apollon Formularies PLC Competitors